BOSTON, October 09, 2023--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today issued an update on its operations in Israel.
"We remain profoundly saddened by the attacks in Israel this weekend and express our deepest condolences to the people of Israel as they mourn the loss of loved ones and defend themselves," said Abbey Jenkins, President and Chief Executive Officer of Gamida Cell. "We have been in touch with our employees in Israel and all are reported safe. We are committed to serving our customers and patients and our manufacturing facility is operational. We thank all our partners and investors who have reached out to express their support. We are continuing to monitor the situation closely and will provide updates as needed."
Gamida Cell issued a statement on Oct. 7 condemning the attacks on Israel and declaring its solidarity with its employees in Israel and the State of Israel, which can be found here.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.